CA Stock MarketDetailed Quotes
FRX Fennec Pharmaceuticals Inc
- 8.930
- +0.020+0.22%
15min DelayMarket Closed Dec 24 13:00 ET
244.97MMarket Cap-165.37P/E (TTM)
8.930High8.930Low100Volume8.930Open8.910Pre Close893.00Turnover15.20052wk High0.00%Turnover Ratio27.43MShares5.65052wk Low-0.054EPS TTM167.96MFloat Cap391.500Historical HighLossP/E (Static)18.81MShs Float0.270Historical Low-0.795EPS LYR0.00%Amplitude--Dividend TTM-32.95P/B1Lot Size--Div YieldTTM
Fennec Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.05%6.97M | 118.41%7.26M | 1,413.24%25.38M | 1,284.50%21.25M | 534.20%9.74M | 6.52M | 3.33M | 1.68M | 1.54M | 1.54M |
| Operating revenue | 15.42%7.99M | 155.08%9.47M | 1,413.24%25.38M | 1,284.50%21.25M | 468.53%8.73M | --6.92M | --3.71M | --1.68M | --1.54M | --1.54M |
| Cost of revenue | 309.97%1.36M | 310.81%608K | 478.95%550K | 1,363.95%1.26M | 696.51%685K | 331K | 148K | 95K | 86K | 86K |
| Gross profit | -9.17%5.62M | 109.44%6.65M | 1,469.34%24.83M | 1,279.78%19.99M | 524.57%9.05M | 6.18M | 3.18M | 1.58M | 1.45M | 1.45M |
| Operating expense | 49.04%10.84M | 49.09%11.69M | 60.37%11.1M | 36.65%33.05M | 42.91%10.94M | -8.67%7.27M | 56.58%7.84M | 94.88%6.92M | 40.43%24.19M | 81.93%7.65M |
| Selling and administrative expenses | 49.14%10.72M | 47.24%11.54M | 61.81%11.08M | 59.50%32.71M | 45.12%10.84M | 1.93%7.19M | 102.04%7.84M | 224.70%6.85M | 67.51%20.51M | 102.69%7.47M |
| -Selling and marketing expense | 35.96%4.6M | 99.66%4.67M | 105.81%5.21M | 335.30%12.12M | 38.89%3.87M | --3.38M | --2.34M | --2.53M | --2.79M | --2.79M |
| -General and administrative expense | 60.87%6.12M | 24.91%6.86M | 36.02%5.87M | 16.16%20.59M | 48.83%6.97M | -46.05%3.81M | 41.70%5.5M | 104.69%4.32M | 44.76%17.72M | 27.09%4.68M |
| Research and development costs | 708.33%97K | 1,862.50%157K | -25.00%3K | -98.41%56K | -72.65%32K | -98.58%12K | -99.29%8K | -99.72%4K | -29.11%3.53M | -77.63%117K |
| Depreciation amortization depletion | -70.83%21K | ---- | -72.22%20K | 92.62%287K | 0.00%70K | 12.50%72K | ---- | 928.57%72K | --149K | --70K |
| -Depreciation and amortization | -70.83%21K | ---- | -72.22%20K | 92.62%287K | 0.00%70K | 12.50%72K | ---- | 928.57%72K | --149K | --70K |
| Operating profit | -379.61%-5.22M | -7.99%-5.04M | 356.89%13.72M | 42.57%-13.06M | 69.57%-1.89M | 86.32%-1.09M | 6.85%-4.67M | -50.35%-5.34M | -32.02%-22.74M | -47.49%-6.21M |
| Net non-operating interest income (expenses) | 32.49%-509K | 36.53%-497K | -21.48%-837K | -277.14%-2.95M | -35.36%-800K | -693.68%-754K | -1,298.21%-783K | -1,306.12%-689K | -789.77%-783K | -936.84%-591K |
| Non-operating interest income | 405.88%516K | 395.65%570K | 80.73%197K | 126.15%441K | -24.84%115K | 325.00%102K | 1,177.78%115K | 1,111.11%109K | 261.11%195K | 1,076.92%153K |
| Non-operating interest expense | 19.74%1.03M | 26.55%1.04M | 29.57%1.03M | 247.03%3.39M | 22.98%915K | 619.33%856K | 1,347.37%825K | 1,275.86%798K | 676.19%978K | 1,100.00%744K |
| Total other finance cost | ---- | -68.49%23K | ---- | ---- | ---- | ---- | 812.50%73K | ---- | ---- | ---- |
| Other net income (expenses) | 87.50%-3K | -440.00%-17K | -133.33%-49K | 82.38%-34K | 109.84%6K | 22.58%-24K | 171.43%5K | 77.66%-21K | -451.43%-193K | 62.58%-61K |
| Gain on sale of security | 87.50%-3K | -440.00%-17K | -133.33%-49K | 82.38%-34K | 109.84%6K | 22.58%-24K | 171.43%5K | 77.66%-21K | -451.43%-193K | 62.58%-61K |
| Income before tax | -207.18%-5.74M | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -207.18%-5.74M | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M |
| Net income continuous operations | -207.18%-5.74M | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -207.18%-5.74M | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -207.18%-5.74M | -2.00%-5.55M | 312.11%12.84M | 32.34%-16.05M | 60.89%-2.68M | 76.92%-1.87M | -7.33%-5.44M | -63.74%-6.05M | -36.71%-23.71M | -54.89%-6.86M |
| Diluted earnings per share | -200.00%-0.21 | 4.76%-0.2 | 304.35%0.47 | 33.33%-0.6 | 60.00%-0.1 | 77.42%-0.07 | -10.53%-0.21 | -64.29%-0.23 | -34.33%-0.9 | -47.06%-0.25 |
| Basic earnings per share | -200.00%-0.21 | 4.76%-0.2 | 278.26%0.41 | 33.33%-0.6 | 60.00%-0.1 | 77.42%-0.07 | -10.53%-0.21 | -64.29%-0.23 | -34.33%-0.9 | -47.06%-0.25 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Price
% Chg
No Data